Tandem Diabetes Care Files 8-K on Agreements and Shareholder Votes
Ticker: TNDM · Form: 8-K · Filed: May 23, 2025 · CIK: 1438133
| Field | Detail |
|---|---|
| Company | Tandem Diabetes Care Inc (TNDM) |
| Form Type | 8-K |
| Filed Date | May 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, shareholder-vote, corporate-action
Related Tickers: TNDM
TL;DR
Tandem Diabetes Care filed an 8-K for a new deal and shareholder vote. Details to follow.
AI Summary
On May 21, 2025, Tandem Diabetes Care, Inc. filed an 8-K report detailing two key events. The company entered into a Material Definitive Agreement and submitted matters to a vote of its security holders. Specific details regarding the nature of the agreement and the matters voted upon were not fully disclosed in the provided excerpt.
Why It Matters
This filing indicates significant corporate actions by Tandem Diabetes Care, potentially impacting its business operations, financial standing, or strategic direction.
Risk Assessment
Risk Level: medium — The filing indicates material definitive agreements and shareholder votes, which can carry inherent risks depending on their nature and outcome.
Key Numbers
- 001-36189 — SEC File Number (Identifies the company's filing with the SEC.)
- 20-4327508 — I.R.S. Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Tandem Diabetes Care, Inc. (company) — Registrant
- May 21, 2025 (date) — Date of earliest event reported
- 12400 High Bluff Drive (address) — Principal executive offices
- San Diego (location) — City of principal executive offices
- 92130 (zip_code) — ZIP code of principal executive offices
- 858-366-6900 (phone_number) — Registrant's telephone number
FAQ
What is the nature of the Material Definitive Agreement entered into by Tandem Diabetes Care?
The provided excerpt does not specify the details of the Material Definitive Agreement.
What specific matters were submitted to a vote of Tandem Diabetes Care's security holders?
The excerpt mentions that matters were submitted to a vote, but does not detail what those matters are.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 21, 2025.
What is Tandem Diabetes Care's principal executive office address?
The principal executive offices are located at 12400 High Bluff Drive, San Diego, California, 92130.
What is the SEC file number for Tandem Diabetes Care?
The SEC file number for Tandem Diabetes Care is 001-36189.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 regarding TANDEM DIABETES CARE INC (TNDM).